Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.
作者信息
Wang Allan, Foster Keyana, Skeba Patrick, Hiranniramol Kasidet, Earley Christopher J, Allen Richard P
机构信息
Center for Restless Legs Study, Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Center for Restless Legs Study, Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
出版信息
Sleep Med. 2018 Dec;52:80-87. doi: 10.1016/j.sleep.2018.08.005. Epub 2018 Aug 17.
Abstract
摘要
相似文献
1
Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.急性停药期不宁腿综合征症状变化的评估。
Sleep Med. 2018 Dec;52:80-87. doi: 10.1016/j.sleep.2018.08.005. Epub 2018 Aug 17.
2
Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.不宁腿综合征/Willis-Ekbom病的多导睡眠图记录及增恶现象的成功处理
Sleep Med. 2014 May;15(5):570-5. doi: 10.1016/j.sleep.2014.01.016. Epub 2014 Mar 21.
3
Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.一名不宁腿综合征患者的多巴胺激动剂戒断综合征
Parkinsonism Relat Disord. 2013 Feb;19(2):269-70. doi: 10.1016/j.parkreldis.2012.06.006. Epub 2012 Jun 29.
4
Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.一名无冲动控制障碍或药物滥用的不安腿综合征患者的多巴胺激动剂戒断综合征
Neurol Sci. 2015 Jun;36(6):1021-3. doi: 10.1007/s10072-014-1996-x. Epub 2014 Nov 2.
5
Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.特发性不安腿综合征中 D2 或 D3 多巴胺激动剂的选择。
Neurology. 2011 Jul 12;77(2):110-7. doi: 10.1212/WNL.0b013e3182242d91. Epub 2011 Jun 29.
6
First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.普拉克索治疗不宁腿综合征和周期性腿部运动的首夜疗效。
Sleep Med. 2007 Aug;8(5):491-7. doi: 10.1016/j.sleep.2006.10.008. Epub 2007 May 18.
7
Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.两名患有不安腿综合征和冲动控制障碍的患者在停用多巴胺激动剂后出现重度抑郁症。
Sleep Med. 2013 Jul;14(7):696. doi: 10.1016/j.sleep.2013.04.009. Epub 2013 May 25.
8
Opioid-induced hyperalgesia and dopamine-induced augmentation in an intractable and refractory case of RLS.阿片类药物诱导的痛觉过敏和多巴胺诱导的增强在一例难治性不宁腿综合征病例中的表现
Sleep Med. 2015 Oct;16(10):1304. doi: 10.1016/j.sleep.2015.08.005. Epub 2015 Aug 18.
9
A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.普拉克索用于不安腿综合征症状治疗的剂量范围研究：周期性腿部运动和睡眠障碍的多导睡眠图评估
Sleep Med. 2009 Jun;10(6):630-6. doi: 10.1016/j.sleep.2008.05.014. Epub 2009 Jan 25.
10
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.与正常人相比，不安腿综合征患者的睡眠实验室研究及罗匹尼罗的急性效应。1. 客观和主观睡眠及觉醒质量的研究结果。
Neuropsychobiology. 2000;41(4):181-9. doi: 10.1159/000026658.
引用本文的文献
1
Moderate to severe but not mild RLS is associated with greater sleep-related sympathetic autonomic activation than healthy adults without RLS.与无不安腿综合征的健康成年人相比，中度至重度而非轻度不安腿综合征与睡眠相关的交感自主神经激活程度更高有关。
Sleep Med. 2020 Apr;68:89-95. doi: 10.1016/j.sleep.2019.09.005. Epub 2019 Oct 5.
本文引用的文献
1
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.不宁腿综合征/Willis-Ekbom病一线治疗、多巴胺能药物增敏的预防和治疗指南：国际不宁腿综合征研究组、欧洲不宁腿综合征参考网络及不宁腿综合征基金会联合特别工作组
Sleep Med. 2016 May;21:1-11. doi: 10.1016/j.sleep.2016.01.017. Epub 2016 Feb 23.
2
Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.长期多巴胺能治疗期间不宁腿综合征（ Willis-Ekbom病）的加重
Postgrad Med. 2015;127(7):716-25. doi: 10.1080/00325481.2015.1058140. Epub 2015 Jun 16.
3
Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.不宁腿综合征/Willis-Ekbom病诊断标准：更新后的国际不宁腿综合征研究组（IRLSSG）共识标准——病史、基本原理、描述及意义
Sleep Med. 2014 Aug;15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. Epub 2014 May 17.
4
The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.不宁腿综合征/ Willis-Ekbom 病的长期治疗：循证指南和临床共识最佳实践指南：国际不宁腿综合征研究组的报告。
Sleep Med. 2013 Jul;14(7):675-84. doi: 10.1016/j.sleep.2013.05.016.
5
Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).不宁腿综合征（ Willis-Ekbom 病）患者日间发作的症状。
Sleep Med. 2012 Feb;13(2):151-5. doi: 10.1016/j.sleep.2011.09.015. Epub 2012 Jan 26.
6
Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics.在西欧的一个大型初级医疗保健患者样本中，医生诊断的不安腿综合征：患病率和特征。
Sleep Med. 2010 Jan;11(1):31-7. doi: 10.1016/j.sleep.2009.03.007. Epub 2009 May 22.
7
Validation of the Hopkins telephone diagnostic interview for restless legs syndrome.霍普金斯不安腿综合征电话诊断访谈的验证
Sleep Med. 2008 Mar;9(3):283-9. doi: 10.1016/j.sleep.2007.04.021. Epub 2007 Jul 17.
8
Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation.不宁腿综合征中的药物耐受性与增效作用：药物类别轮换的必要性。
J Gen Intern Med. 2006 Dec;21(12):C1-4. doi: 10.1111/j.1525-1497.2006.00593.x.
9
Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.普拉克索治疗特发性不宁腿综合征的疗效与安全性：一项多导睡眠图剂量探索研究——前奏研究
Sleep Med. 2006 Aug;7(5):407-17. doi: 10.1016/j.sleep.2006.03.011. Epub 2006 Jul 3.
10
The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG).世界睡眠医学协会（WASM）与国际不宁腿综合征研究组（IRLSSG）的一个特别工作组合作制定的关于记录和评分睡眠期周期性腿部运动（PLMS）和清醒期周期性腿部运动（PLMW）的官方标准。
Sleep Med. 2006 Mar;7(2):175-83. doi: 10.1016/j.sleep.2006.01.001. Epub 2006 Feb 3.
Zotero 插件